Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
BMC Cancer
Published in: BMC Cancer 1/2015

Open Access 01-12-2015 | Correspondence

An early warning surveillance programme for detecting upper limb deterioration after treatment for breast cancer: A novel technology supported system

Authors: Delva Shamley, Karen Robb

Published in: BMC Cancer | Issue 1/2015

Login to get access

Abstract

Upper limb morbidity is a well-recognised consequence of treatment for breast cancer that can develop for up to 6 years after treatment. However, the capacity to fully integrate evidence-based rehabilitation pathways into routine care for all patients is questionable due to limited resources. A long term surveillance programme must therefore be accessible to all patients, should identify those at risk of developing morbidity and target the interventions at the high risk population of patients. The proposed model uses a surrogate marker for assessing risk of morbidity, incorporated into an Early Warning System (EWS), to produce a technology-lead, prospective surveillance programme.
Literature
1.
Rich K. In-hospital cardiac arrest: pre-event variables and nursing response. Clinical Nurse Specialist. 1999;13:147–53.CrossRefPubMed
2.
MacArthur-Rouse F. Critical care outreach services and early warning scoring systems:a review of the literature. J Adv Nursing. 2001;36(5):696–704.CrossRef
3.
Hiding JT, Beursken CHG, Van der Wees PJ, Van Laarhaven HW and Nijhuis-van der Sanden MW. Treatment related impairments in arm and shoulder in patients with breast cancer: A systematic Review. PLOS ONE. 2014;9(5):1–17.
4.
5.
Lee TS, Kilbreath SL, Refshauge KM, Beith JM and Harris LM. Prognosis of the upper limb following surgery and radiation for breast cancer. Br Canc Res Treatment. 2008;110:19–37.
6.
Andersen K, Jensen M, Kehlet H, Gartner R, Eckhoff L and Kroman N. Persistent pain, sensory disturbances and functional impairment after adjuvant chemotherapy for breast cancer: cyclophosphamide, epirubicin and fluorouracil compared with docetaxel + epirubicin and cyclophosphamide. Acta Oncol. 2012;51(8):1036–44.
7.
Gärtner R, Jensen M, Nielsen J, Ewert M, Kroman N and Kehlet H. Prevalence of and factors associated with persistent pain following breast cancer surgery. JAMA. 2009;302(18):1985–92.
8.
Shamley D, Srinaganathan R, Oskrochi R, lascurain-Aguirrebena I and Sugden E. Three-dimensional scapulothoracic motion following treatment for breast cancer. Br Canc Res and Treatment. 2009;118(2):315–22.
9.
Shamley D, Srinaganathan R, Weatherall R, Oskrochi R, Watson M, Ostlere S and Sugden E. Changes in shoulder muscle size and activity following treatment for breast cancer. Br Canc Res and Treatment. 2007;106(1):19–27.
10.
Schmitz KH, Speck RM, Ryae SA, DeSipio T and Hayes SC. Prevalence of breast cancer treatment sequelae over 6 years of follow-up: The Pulling Through Study. Cancer. 2012;118(8):2217–25.
11.
12.
Katz J, Pleshuck EL, Katz J, Andrus CH, Hogan LA and Jung BF, et al. Risk factors for acute postoperative pain and its persistence following breast cancer surgery: a prospective study. Pain. 2005;119:16–25.
13.
Williams Jr JW, Holleman Jr DR and Simel DL. Measuring shoulder function with the Shoulder Pain and Disability Index. J Rheumatol. 1995;22:727–32.PubMed
14.
Hayes SC, Johansson K, Stout N, Prosnitz R, Armer JM, Gabram S and Schmitz KH. Upper-body morbidity after breast cancer. Cancer. 2012;15:2237–49.
15.
16.
Torres Lacomba M, Yuste Sanchez MJ, Zapico Goni A, Prieto Merino D, Mayoral del Moral O, Cerezo Tellez E and Minayo Mogollan E. Effectiveness of early physiotherapy to prevent lymphoedema after surgery for breast cancer: randomised, single blinded, clinical trial. BMJ. 2010;340:b5396.
17.
Stout N, Binkley JM, Schmitz KH, Andrews K, Hayes SC, Campbell KL, McNeely ML, Saballe PW et. al. A prospective surveillance model of rehabilitation for women with breast cancer. Cancer. 2012;15:2191–200.
18.
Metadata
Title
An early warning surveillance programme for detecting upper limb deterioration after treatment for breast cancer: A novel technology supported system
Authors
Delva Shamley
Karen Robb
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2015
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-015-1636-8

Other articles of this Issue 1/2015

BMC Cancer 1/2015 Go to the issue

Research article

Prospective cohort study using the breast cancer spheroid model as a predictor for response to neoadjuvant therapy – the SpheroNEO study

Research article

A population based perspective on children and youth with brain tumours

Case report

Somatic and germline analyses of a long term melanoma survivor with a recurrent brain metastasis

Research article

Berberine, a natural compound, suppresses Hedgehog signaling pathway activity and cancer growth

Research article

The association of alcohol consumption with mammographic density in a multiethnic urban population

Research article

Association between praziquantel treatment and cholangiocarcinoma: a hospital-based matched case–control study
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits